Johnson & Johnson Falls Short of Sector Gains as Earnings Loom

Johnson & Johnson (JNJ) closed at $263.40 on its latest trading session, marking a -1.44% move from the previous day.

The stock fell short of the S&P 500's loss of 0.28%, but outpaced the Dow's drop of 1.09% and the Nasdaq's gain of 0.2%

Over the past month, shares of JNJ have gained 12.76%, surpassing the Medical sector's gain of 7.8% and the S&P 500's gain of 1.64%

Market participants are anticipating Johnson & Johnson's financial results, scheduled for release on July 15, 2026

The company is projected to report earnings of $2.83 per share, representing year-over-year growth of 2.17%, and revenue of $25.11 billion, indicating a 5.75% increase compared to the corresponding quarter of the prior year